Press Release: Latest Medical and Scientific Advances for Gynecologic Cancers Presented in First Annual “State of the State of Gynecologic Cancers”

Chicago, September 29, 2003—The Gynecologic Cancer Foundation (GCF) has released the “State of the State of Gynecologic Cancers—First Annual Report to the Women of America,” detailing the most recent advances in the detection and treatment of gynecologic cancers. It is the first report to provide critical information about symptoms, risk factors, screening/prevention methods and incidence figures for these cancers, which affect more than 80,000 women in the U.S. each year, according to the American Cancer Society.

The report, which will be distributed by GCF each year during September, Gynecologic Cancer Awareness Month, contains information about the most common gynecologic cancers that affect women in the U.S. These are: cervical cancer, ovarian cancer (epithelial and stromal cell/germ cell), uterine cancer (endometrial and uterine sarcomas), vaginal cancer and vulvar cancer. According to the American Cancer Society, approximately 26,000 women die from gynecologic cancers each year.

“The State of the State of Gynecologic Cancers shows the powerful progress that has been made in detecting and treating gynecologic cancers,” said GCF Chairman Karl C. Podratz, M.D., Ph.D. “Most importantly however, it shows women that early recognition of symptoms and regular gynecologic screening are the best tools at a woman’s disposal to maintain gynecologic health.”

“We hope that by providing women with the latest information about gynecologic cancers, we can help them to actively manage their health, and to be aware of risk factors and symptoms so they know when to seek support and treatment,” said Bobbie Gostout, M.D., who edited the report. “Ultimately, by informing women of these diseases, we believe this report detailing gynecologic cancer facts and progress will become a report of hope for women—and their families—who are affected by these cancers.”

“The State of the State of Gynecologic Cancers” can be viewed online and downloaded at the Women’s Cancer Network: To receive a copy by mail, please contact Dan Hewitt by e-mail or by phone at 202-530-4695.

Click Here for the Report in PDF Format

The Gynecologic Cancer Foundation is a not-for-profit charitable organization established by the Society of Gynecologic Oncologists in 1991 to support research related to gynecologic cancers, to fund training of clinician scientists, and to increase public awareness and information related to gynecologic cancers and their precursors. The mission of the Gynecologic Cancer Foundation (GCF) is to ensure public awareness of gynecologic cancer prevention, early diagnosis and proper treatment. GCF advances this mission by increasing public and private funds that aid in the development and implementation of programs to meet these goals. GCF was named by Worth Magazine as one of “America’s 100 Best Charities.” Of the 26 health organizations listed, GCF was one of only two organizations solely focused on women’s health. For more information, please visit or call 1.800.444.4441.


Visit the Sisterhood of Survivorship page to read “Dena’s Story” — by a vulvar cancer survivor who has shared her story and wise words, and channeled her energy into her National Race to End Women’s Cancer team.


Vaccine efficacy against vulvar infection with HPV 16/18 was comparable to the efficacy found against cervical infection 4 years after vaccination, according to researchers with the National Cancer Institute.


The Foundation has published its 2014-2015 Research Grants and Awards Booklet with Applications. Please consider applying to become part of an elite group of physician-scientists committed to the well-being of women at risk for/affected by gyn malignancies.


The next Ovarian Cancer Survivors Course will be Saturday, July 26, 2014 in Boston. For more information on courses, click here.